Results 301 to 310 of about 3,310,854 (363)
Some of the next articles are maybe not open access.
Allergy to Dermatologic Agents
JAMA: The Journal of the American Medical Association, 1966Between 1962 and 1965, 78 cases of allergy to topically administered medicaments were documented in the author's private practice. In 60 of the 78 patients the allergy had been responsible for causing or aggravating a dermatitis. Antimicrobials, antihistamines, and anesthetics were the most prominent allergens with neomycin being the single most ...
E. Epstein
openaire +4 more sources
Dermatologic Toxicity of Chemotherapeutic Agents
Seminars in Oncology, 2006Due to its high metabolic rate, skin represents one of the major target organs of chemotherapy-associated toxicity. Reactions range from common, nonspecific exanthematous eruptions to rare but distinctive cutaneous lesions that may not become apparent until a drug transitions from clinical trials to widespread oncologic use.
Raymond B. Weiss +2 more
openaire +3 more sources
DERMATOLOGIC SIDE EFFECTS OF PSYCHOPHARMACOLOGIC AGENTS
Dermatologic Clinics, 1996Exanthematous eruptions, urticaria, photosensitivity, pigmentary problems, acne, alopecia, fixed drug eruptions, and lichenoid reactions are the most common dermatologic side effects associated with the administration of psychopharmacologic agents. The cutaneous findings associated with the various eruptions and the most common inciting psychiatric ...
S. Garnis-Jones
openaire +4 more sources
REVIEW: Topical Hemostatic Agents for Dermatologic Surgery
The Journal of Dermatologic Surgery and Oncology, 1988Abstract. Topical hemostatic agents are very helpful in attaining capillary and small vessel hemostasis in dermatologic surgery. The commonly used topical hemostatic agents, including oxidized cellulose, absorbable gelatin, and thrombin are reviewed, along with newer agents such as microfibrillar collagen, fibrin sealants, and acrylates.
P. Larson
openaire +4 more sources
Antifungal agents in dermatology
Journal of the American Academy of Dermatology, 1987Development of new antifungal agents has increased significantly over the past two decades, with recent advances reflecting interest in synthetic agents as opposed to antibiotics. We review the various antifungal medications in use or under development, beginning with a discussion of over-the-counter agents, antibiotics, and older azole compounds and ...
J. Graham Smith, Jack L. Lesher
openaire +3 more sources
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2020
Over the past 2 decades, rapid advancement in systemic anticancer therapeutics has led to astounding improvement in survival rates of patients with cancer. However, this celebrated progress has brought with it an evolving spectrum of drug toxicities that
A. Deutsch +3 more
semanticscholar +1 more source
Over the past 2 decades, rapid advancement in systemic anticancer therapeutics has led to astounding improvement in survival rates of patients with cancer. However, this celebrated progress has brought with it an evolving spectrum of drug toxicities that
A. Deutsch +3 more
semanticscholar +1 more source
Immunosuppressive Agents in Dermatology
Dermatologic Clinics, 1993Azathioprine, cyclophosphamide, and cyclosporine are immunosuppressive agents commonly used by dermatologists. Azathioprine has a good safety profile and is preferred by most dermatologists for the treatment of bullous pemphigoid, cutaneous vasculitides, chronic eczematous dermatitides, and cutaneous manifestations of connective tissue diseases.
V C, Ho, D M, Zloty
openaire +2 more sources